Transforming medicine with the microbiome

Niv Zmora^{1

2

3}, Eliran Soffer¹, Eran Elinav⁴

Affiliations

¹ Immunology Department, Weizmann Institute of Science, Rehovot 7610001, Israel.
² Digestive Center, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
³ Internal Medicine Department, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
⁴ Immunology Department, Weizmann Institute of Science, Rehovot 7610001, Israel. eran.elinav@weizmann.ac.il.

Review

Niv Zmora et al. Sci Transl Med. 2019.

. 2019 Jan 30;11(477):eaaw1815.

doi: 10.1126/scitranslmed.aaw1815.

Niv Zmora^{1

2

3}, Eliran Soffer¹, Eran Elinav⁴

¹ Immunology Department, Weizmann Institute of Science, Rehovot 7610001, Israel.
² Digestive Center, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
³ Internal Medicine Department, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
⁴ Immunology Department, Weizmann Institute of Science, Rehovot 7610001, Israel. eran.elinav@weizmann.ac.il.

Abstract

Advances in microbiome research are spurring the development of new therapeutics for a variety of diseases, but translational challenges remain.